US EditionOver 580,000 bottles of blood pressure medication recalled nationwide
Teva Pharmaceuticals recalled over 580,000 bottles of Prazosin Hydrochloride due to nitrosamine impurities that may increase cancer risk with long-term exposure, FDA said.
- Teva Pharmaceuticals USA Inc. initiated a voluntary recall of over 580,000 prazosin hydrochloride bottles distributed nationwide, according to the FDA.
- After testing, regulators flagged elevated nitrosamine levels as N-nitroso Prazosin impurity C above acceptable intake limits, and the FDA classified the recall as Class II on Oct. 24.
- The recall covers three dosage strengths with detailed counts: 1 mg capsules in 181,659 bottles, 2 mg in 291,512 bottles, and 5 mg in 107,673 bottles, with packaging from 100 to 1,000 capsules.
- Patients affected should consult their healthcare provider as soon as possible because sudden discontinuation can pose health risks, and Teva Pharmaceuticals USA Inc. notified customers by letter while the recall remains ongoing.
- Nitrosamines are a class of known carcinogens and may increase cancer risk with long-term exposure, yet neither Teva Pharmaceuticals USA Inc. nor the U.S. Food and Administration issued disposal guidance while GoodRx urged checking lot numbers.
42 Articles
42 Articles
FDA pulls hundreds of thousands of blood pressure pills over impurity
The U.S. Food and Drug Administration has ordered the recall of over 580,000 bottles of a commonly prescribed blood pressure drug after tests revealed unsafe levels of a potentially carcinogenic impurity.
NBC Chicago
NBC Dallas-Fort WorthPopular blood pressure medication recalled over high levels of cancer-causing chemical
Nearly half-a-million bottles of the medication were recalled after tests showed capsules had high levels of potentially cancer-causing chemicals.
Blood Pressure Medication Recalled Due to Possible Carcinogens
More than 580,000 bottles of blood pressure medication are being recalled across the United States due to possible carcinogenic substances, according to a notice from the Food and Drug Administration (FDA). The recall involves three separate lots of prazosin hydrochloride, a type of alpha-blocking medication, that were distributed by New Jersey-based Teva Pharmaceuticals, because a test result for N-nitroso Prazosin impurity C found that the sub…
Coverage Details
Bias Distribution
- 87% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
